Mexico Oncology Clinical Trials Market Analysis

Mexico Oncology Clinical Trials Market Analysis

$ 3999

Mexico's oncology clinical trials market is projected to grow from $189.8 Mn in 2022 to $296.8 Mn by 2030, registering a CAGR of 5.75% during the forecast period of 2022-30. The market will be driven by the country's growing expertise and infrastructure, as well as its commitment to international collaboration. The market is segmented by phase, by study design & by indication. Some of the major players include Pfizer Inc., Novartis International AG & Laboratorios Silanes.

ID: IN10MXCT006 CATEGORY: Clinical Trials GEOGRAPHY: Mexico AUTHOR: Vidhi Upadhyay

Buy Now

Mexico Oncology Clinical Trials Market Executive Summary

Mexico's oncology clinical trials Market is projected to grow from $189.8 Mn in 2022 to $296.8 Mn by 2030, registering a CAGR of 5.75% during the forecast period of 2022-30. Mexico is Latin America's second-largest pharmaceutical market and is in the top 15 worldwide pharma markets. In addition, there are significant chances for pharmaceutical firms in Mexico. Almost 90% of Mexico's pharmaceutical manufacturing is for the domestic market. Mexico has executed an enormous number of Free Trade Agreements (with over 30 nations, including Canada, the United States, Japan, Israel, and others). Prostate, colorectal, testicular, lung, and stomach cancer are the most prevalent kinds of cancer among Mexican males. Breast, thyroid, cervical, uterine corpus, and colorectal cancer are the most common cancers among Mexican women.

Mexico is a regional leader in oncology clinical trials, with an increasing number of research focusing on cancer therapy and prevention. The nation has a huge patient population and a well-established healthcare system, which has aided in the expansion of clinical trials in the sector. The discovery of novel cancer medicines, especially immunotherapy and targeted therapies, is one of the primary areas of emphasis for oncology clinical trials in Mexico. There are also multiple current research on cancer screening and early diagnosis, as well as investigations on the underlying genetic and molecular causes of various forms of cancer. While there are both opportunities and challenges in the Mexican oncology clinical trials scenario, the country's growing expertise and infrastructure, as well as its commitment to international collaboration, indicate that it will continue to play a significant role in the global oncology trials landscape.

mexico oncology clinical trials market analysis

Market Dynamics

Market Growth Drivers

In Mexico, there are numerous important drivers of growth for cancer clinical trials. The country's vast patient population and reasonably well-established healthcare system, which offers a solid platform for clinical research, are two of the most crucial aspects. Moreover, Mexico has an expanding network of research institutes and clinical trial locations, which is assisting in the expansion of cancer clinical trials. In the domain, there is also a major emphasis on innovation and cooperation, with several research institutes and pharmaceutical firms collaborating to create novel cancer treatments and medications. Additionally, the country's clinical trial regulatory environment has greatly improved in recent years, making it simpler and more economical to conduct high-quality studies that match international standards.

Market Restraints

There are also various obstacles to the expansion of cancer clinical trials in Mexico. One significant difficulty is the scarcity of clinical trial financing, especially for smaller or independent research institutes. A lack of skilled staff, such as clinical trial coordinators, data managers, and regulatory professionals, may also make it difficult to run high-quality clinical trials that match international standards. Another restraint is overcoming cultural and language obstacles to clinical trial participation, especially among underprivileged populations. This necessitates a greater emphasis on community participation and education, as well as measures to promote diversity and inclusion in clinical trial design and recruitment.

Competitive Landscape

Key Players

  • Pfizer Inc.
  • Novartis International AG
  • Roche Holding AG
  • Sanofi S.A.
  • AstraZeneca plc
  • Merck & Co., Inc.
  • Eli Lilly and Company
  • Bristol Myers Squibb Company
  • Laboratorios Silanes (MEX)
  • Grupo Ferrer (MEX)

Notable Insights

  1. January 2023, The University of New Mexico Comprehensive Cancer Center will soon investigate the possibility of treating advanced prostate cancer using cutting-edge radioisotope technology known as 177 Lu-PSMA-617. The University of New Mexico Cancer Center will be one of just a few institutions in the nation to take part in a clinical study to extend the use of theranostic therapy to patients with prostate cancer.
  2. February 2022, A new clinical study at The University of New Mexico Comprehensive Cancer Center may help individuals with unusual cancer mutations get individualized cancer treatment.

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Clinical Trials Regulation in Country
1.6 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share
4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company Overview Product Applications and Services Recent Developments Partnerships Ecosystem Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation

6. Methodology and Scope

Oncology Clinical Trials Market Segmentation

By Phase (Revenue, USD Billion):

  • Phase I
  • Phase II
  • Phase III
  • Phase IV

By Study Design Outlook (Revenue, USD Billion):

  • Epilepsy
  • Parkinson's Disease (PD)
  • Huntington's Disease
  • Stroke
  • Traumatic Brain Injury (TBI)
  • Amyotrophic Lateral Sclerosis (ALS)
  • Muscle regeneration
  • Others

By Indication Outlook  (Revenue, USD Billion):

  • Interventional
  • Observational
  • Expanded Access

Insights10 will provide you with the reports within 10 key parameters which are:

  1. Market Overview
  2. Market Growth Drivers & Restraints
  3. Epidemiology of Disease Type
  4. Market Segmentation
  5. Market Share
  6. Competitive Landscape
  7. Key Company Profiles
  8. Healthcare Policies & Regulatory Framework
  9. Reimbursement Scenario
  10. Factors Driving Future Growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision-making for business stakeholders. Our focused approach to developing reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.


Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers, and researchers across countries through which we engage with local experts to gather key data points and assumptions about each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain a high level of accuracy and consistency. The market data is analyzed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, and market share as well as a segment-level analysis of the specific market. Our report includes precise, to-the-point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:



Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameters and micro indicators. The macro parameters include changes in government policies, demand and supply of the market, government intervention programs, and major market share. The micro indicators are GDP growth, market size, market volume, etc. We also understand nuances specific to each country like the US, Canada, India, Germany, etc., and have worked across 60+ countries and hence not only understand global trends but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. starting with the large overall market and segmenting different areas and the bottom-up approach i.e. starting with population and epidemiology and rolling up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach is mainly used for new product forecasting and the bottom-up approach is used for demand estimation of any product for different countries summed up to form the total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as Asia-Pacific, Africa, Europe, Middle East, North America, and  Latin America for the period of 2022 to 2030. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape, and policy and regulatory scenario, and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases, and company-level averages, etc.

We make sure to finalize the numbers in alignment with the market research. Firstly, our internal experts ensure thorough validation and checking to ensure accurate and precise analysis and then validation is also done using a multiple-data analysis model. Two-level validation is done and entails the finalization of the report scope and the way of representation pattern.



Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analyzed and synthesized. The second series of interviews are done if necessary to check and validate. The future opportunities are analyzed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results is then, interpreted by considering the following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing the regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue/volume
  • ​Analyzing current needs and determining penetration to estimate the market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and their impact on the different segments within the market.

Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current, and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumption.

The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy of this report, please complete the form below.

We value your inquiry and offer free customization with every report to fulfil your exact research needs.

This report addresses

  • Intelligent insights to take informed business decisions
  • Qualitative, acute and result oriented market analysis
  • Market size and forecasts from 2022 to 2030
  • Opportunities for expansion and in-depth market analysis
  • Segmentation and regional revenue forecasts
  • Analysis of the market share and competitive landscape
  • Strategic Recommendations to chart future course of action
  • Comprehensive Market Research Report in PDF and PPT formats

Need more?

  • Ask our analyst how this study was put together to learn more
  • Discuss additional requirements as part of the free customisation
  • Add more countries or regions to the scope 
  • Get answers to specific business questions 
  • Develop the business case to launch the product
  • Find out how this report may influence your business revenue
Last updated on: 15 June 2023
Updated by: Keta Vora

Related reports (by category)

Related reports (by geography)

subscribe to our newsletter